WUXI BIOLOGICS CAYMAN INC
2269 · Health Care · China
WUXI BIOLOGICS CAYMAN INC (2269) is a company in the Health Care sector, based in China. The stock is held in 2 ETFs we track – with its largest weight of 0.12 % in IS3N (msci-em-imi). That means you can hold WUXI BIOLOGICS CAYMAN INC indirectly and diversified through an ETF savings plan.
Held in2 ETFs
Highest weight0.12 %
SectorHealth Care
CountryChina
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| IS3N | msci-em-imi | 0.12 % |
| IUSQ | msci-acwi | 0.02 % |
Want to know how much WUXI BIOLOGICS CAYMAN INC overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Similar stocks
More names from Health Care · China:
- YUNNAN BAIYAO GROUP LTD A000538
- CHANGCHUN HIGH & NEW TECHNOLOGY IN000661
- HUADONG MEDICINE LTD A000963
- CHINA RESOURCES SANJIU MEDICAL AND000999
- SHANGHAI RAAS BLOOD PRODUCTS LTD A002252
- SHENZHEN SALUBRIS PHARMACEUTICALS002294
- SICHUAN KELUN PHARMACEUTICAL LTD A002422
- HAISCO PHARMACEUTICAL GROUP LTD A002653
- SHANDONG WEIGAO GP MEDICAL POLYMER1066
- CSPC PHARMACEUTICAL GROUP LTD1093
- SINOPHARM GROUP LTD H1099
- JACOBIO PHARMACEUTICALS GROUP LTD1167
Price: US market close (EOD). Not investment advice.